Unique ID issued by UMIN | UMIN000047451 |
---|---|
Receipt number | R000054111 |
Scientific Title | The efficacy of oral nutritional therapy with ENORAS for the patients after gastrectomy and the evaluation for the nutritional index: exploratory prospective study |
Date of disclosure of the study information | 2022/04/10 |
Last modified on | 2024/04/11 15:33:27 |
The efficacy of oral nutritional therapy with ENORAS for the patients after gastrectomy and the evaluation for the nutritional index: exploratory prospective study
Oral nutritional therapy with ENORAS and evaluation for nutritional index after gastrectomy
The efficacy of oral nutritional therapy with ENORAS for the patients after gastrectomy and the evaluation for the nutritional index: exploratory prospective study
Oral nutritional therapy with ENORAS and evaluation for nutritional index after gastrectomy
Japan |
Gastric cancer
Gastrointestinal surgery |
Malignancy
NO
In this study, the purpose is to clarify the correlation between total calorie intake at the 3 months after surgery including the adherence of ENORAS oral intake dose (continuous internal use completion rate) and each nutritional index item such as weight loss rate. In addition, we will explore the more useful index items to evaluate the efficacy of the oral nutritional supplement.
Efficacy
Exploratory
Phase II
Body weight loss rate at 3 months after gastrectomy
The adherence of ENORAS oral intake dose (continuous internal use completion rate), Total calorie intake at the 3 months after surgery (estimate from images or records of meal after gastrectomy), ECOG-PS, Nutritional index from blood test (TP, ALB, TLC), Bioelectrical impedance analysis, Visceral fat area and Skeletal muscle index from CT images
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Oral nutritional supplements for patients after gastrectomy
18 | years-old | <= |
Not applicable |
Male and Female
(1) Gastric cancer patients who are diagnosed to be clinical Stage 1,2 and 3 according to the Japanese classification for gastric cancer and who are going to undergo distal gastrectomy or total gastrectomy
(2) ECOG-PS 0 to 2
(3) Patients who are able to oral intake before gastrectomy
(4) A patient whose written informed consent has been obtained
(1) Patients with allergies to oral nutritional supplements
(2) Patients who are judged unsuitable for the study by the principal investigator or sub-investigator
50
1st name | Shingo |
Middle name | |
Last name | Kanaji |
Graduate School of Medicine, Kobe University
Division of Gastrointestinal Surgery, Department of Surgery
650-0017
7-5-2, Kusunoki-cho, Chuo-ku, Kobe City, Hyogo
078-382-5925
kanashin@med.kobe-u.ac.jp
1st name | Hitoshi |
Middle name | |
Last name | Harada |
Graduate School of Medicine, Kobe University
Division of Gastrointestinal Surgery, Department of Surgery
650-0017
7-5-2, Kusunoki-cho, Chuo-ku, Kobe City, Hyogo
078-382-5925
htharada@med.kobe-u.ac.jp
Kobe University
Kobe University
Other
Kobe Univ. Hosp. Clinical & Translational Research Center
7-5-2, Kusunoki-cho, Chuo-ku, Kobe City, Hyogo
078-382-6669
kainyu@med.kobe-u.ac.jp
NO
神戸大学医学部附属病院
2022 | Year | 04 | Month | 10 | Day |
Unpublished
Open public recruiting
2022 | Year | 04 | Month | 10 | Day |
2022 | Year | 08 | Month | 12 | Day |
2022 | Year | 08 | Month | 12 | Day |
2024 | Year | 11 | Month | 30 | Day |
2022 | Year | 04 | Month | 10 | Day |
2024 | Year | 04 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054111